CME Group Inc.
CME · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 2.56 | 1.19 | 14.88 | 1.29 |
| FCF Yield | 4.31% | 4.47% | 4.92% | 2.78% |
| EV / EBITDA | 16.67 | 16.32 | 15.20 | 21.01 |
| Quality | ||||
| ROIC | 8.51% | 7.35% | 6.37% | 5.57% |
| Gross Margin | 86.13% | 85.15% | 85.00% | 82.15% |
| Cash Conversion Ratio | 1.05 | 1.07 | 1.14 | 0.91 |
| Growth | ||||
| Revenue 3-Year CAGR | 6.89% | 5.96% | 0.92% | -1.24% |
| Free Cash Flow Growth | 6.49% | 13.86% | 30.38% | -9.65% |
| Safety | ||||
| Net Debt / EBITDA | 0.11 | 0.11 | 0.18 | 0.16 |
| Interest Coverage | 24.43 | 21.55 | 18.54 | 15.85 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -0.17 | -4.87 | -23.70 | 12.54 |